Loading clinical trials...
Loading clinical trials...
SPI-1005 is a novel oral drug that contains a glutathione peroxidase mimetic (ebselen) that will be tested in subjects with a history of NIHL at risk for additional NIHL. The goal of this multi-center...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sound Pharmaceuticals, Incorporated
NCT07304024 · Central Auditory Processing Disorder, Hearing Impaired (Partially), and more
NCT04120116 · Sensorineural Hearing Loss, Noise Induced Hearing Loss, and more
University of Miami
Miami, Florida
University of Kansas Medical Center
Kansas City, Kansas
MUSC
Charleston, South Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions